Enhance Recovery. Optimize ICU Resource Utilization.
See how PleuraFlow® Active Clearance Technology® can help free ICU resources and get patients home faster.



Clear Catheter completed a $1.2M series B preferred financing in Q4, 2010

In October, 2010, the company announced it closed an equity financing round with total proceeds of $1.2 million. The financing was led by the Oregon Angel Fund (OAF), joined by additional Oregon based angel investors. The financing will support the clinical launch of the company’s lead product, the PleuraFlow® Active Tube Clearance® System and continued technology development.